AstraZeneca Chief Executive Pascal Soriot
Media playback is unsupported on your device

AstraZeneca boss: Pfizer bid 'could delay drug development'

13 May 2014 Last updated at 18:28 BST

The chief executive of AstraZeneca has warned that new drug development could be hit if it was taken over by Pfizer.

Pascal Soriot told BBC News that a takeover would create huge disruption.